Burzynski, the Movie (2010)

ALL 10/28/2010 (en) Documentary 105 Min
  • Release
    10/28/2010
  • Production
  • Rotten tomato
    63%
  • Original title
    Burzynski, the Movie
  • Original language
    en
  • Production Cost
  • 0.00
    -

Cancer Is Serious Business

Overview

Burzynski, the Movie is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history. His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of FDA testing in 2011–barring the ability to raise the required $300 million to fund the final phase of FDA clinical trials.

  1. Eric Merola

    Director

  2. Story

  3. Editor

  4. Producer



Currently available to stream, watch for free, rent, and buy in the United States. You can makes it easy to find out where you can legally watch your favorite movies & TV shows online.

Watch Channel

Casts

Full Cast & Crew

Casts : 1 , Crews : 1

Keyword

Burzynski, the Movie (2010) 105 Min

ALL 10/28/2010 (en)
Documentary
  • Release 10/28/2010
  • Production
  • Original title Burzynski, the Movie
  • en
  • Revenue0.00

Cancer Is Serious Business

Overview

Burzynski, the Movie is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history. His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of FDA testing in 2011–barring the ability to raise the required $300 million to fund the final phase of FDA clinical trials.

  1. Eric Merola

    Director

  2. Story

  3. Editor

  4. Producer